Dr. Reddy's
RDY
$54.58
Share price
-0.98%
Change (1 day)
4.06%
Change (1 year)
Categories
P/S ratio for Dr. Reddy's (RDY)
P/S ratio as of March 2023 (TTM): 3.05
According to Dr. Reddy's's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.05247. At the end of 2022 the company had a P/S ratio of 2.89.
P/S ratio history for Dr. Reddy's from 2002 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 2.89 | -26.07% |
| 2021 | 3.91 | -16.48% |
| 2020 | 4.69 | 70.98% |
| 2019 | 2.74 | -4.55% |
| 2018 | 2.87 | 1.04% |
| 2017 | 2.84 | -18.93% |
| 2016 | 3.51 | 6.16% |
| 2015 | 3.30 | -10.72% |
| 2014 | 3.70 | 16.68% |
| 2013 | 3.17 | 7.07% |
| 2012 | 2.96 | 10.44% |
| 2011 | 2.68 | -32.84% |
| 2010 | 3.99 | 46.9% |
| 2009 | 2.72 | 135.8% |
| 2008 | 1.15 | -51.72% |
| 2007 | 2.39 | -2.21% |
| 2006 | 2.44 | -23.81% |
| 2005 | 3.20 | -7.06% |
| 2004 | 3.45 | -44.84% |
| 2003 | 6.25 | -9.28% |
| 2002 | 6.89 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 3.41 | 11.78% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.30 | -24.79% | 🇺🇸 USA |
 Sanofi SNY | 2.52 | -17.54% | 🇫🇷 France |
 GlaxoSmithKline GSK | 1.84 | -39.83% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 0.6349 | -79.20% | 🇮🇱 Israel |